rs796053377
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001032221.6(STXBP1):c.1702+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001032221.6 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STXBP1 | NM_003165.6 | c.1702+1G>A | splice_donor_variant, intron_variant | Intron 18 of 19 | ENST00000373302.8 | NP_003156.1 | ||
STXBP1 | NM_001032221.6 | c.1702+1G>A | splice_donor_variant, intron_variant | Intron 18 of 18 | ENST00000373299.5 | NP_001027392.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STXBP1 | ENST00000373302.8 | c.1702+1G>A | splice_donor_variant, intron_variant | Intron 18 of 19 | 1 | NM_003165.6 | ENSP00000362399.3 | |||
STXBP1 | ENST00000373299.5 | c.1702+1G>A | splice_donor_variant, intron_variant | Intron 18 of 18 | 1 | NM_001032221.6 | ENSP00000362396.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Not observed in large population cohorts (Lek et al., 2016); Deletions involving coding exons in this gene are frequently reported as pathogenic, regardless of frame prediction (Stenson et al., 2014); This variant is associated with the following publications: (PMID: 29655203, 31344879, 30654231) -
- -
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
This sequence change affects a donor splice site in intron 18 of the STXBP1 gene. While this variant is not anticipated to result in nonsense mediated decay, it likely alters RNA splicing and results in a disrupted protein product. This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with clinical features of early infantile epileptic encephalopathy (Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 207444). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts the p.Thr574 amino acid residue in STXBP1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 21770924). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
STXBP1-associated neurodevelopmental disorder Pathogenic:1
- -
Infantile epilepsy syndrome Pathogenic:1
Submission from Simons Searchlight facilitated by GenomeConnect. Variant interpreted by the Simons Searchlight team most recently on 2018-12-03 and interpreted as Likely Pathogenic. Variant was initially reported on 2018-10-11 by GTR ID of laboratory name 500031. The reporting laboratory might also submit to ClinVar. -
Developmental and epileptic encephalopathy, 4 Pathogenic:1
This variant was identified as de novo (maternity and paternity confirmed). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at